Roger J M Brüggemann

55PUBLICATIONS
157CO-AUTHORS
Medical infection agents (incl. prions)Environmental epidemiologyInfant and child healthRespiratory diseasesEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jul 22, 2026
Physiologically based pharmacokinetic (PBPK) model to predict the magnitude of drug-drug interaction between vincristine and the azole antifungals isavuconazole, posaconazole, and voriconazole in children.

|Jul 13, 2026
Antifungal exposure in Scedosporium septic arthritis: synovial penetration of voriconazole and terbinafine and plasma concentrations of olorofim.

|Apr 20, 2026
Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.

|Jan 29, 2026
Do the redefined EUCAST susceptibility categories warrant adjustment of paediatric antibiotic dosages? Pragmatic physiologically based pharmacokinetic modelling of four commonly used agents.

Marika A de Hoop-Sommen, Jolien J M Freriksen, Joyce E M van der Heijden

|Jan 21, 2026
Real-world evaluation of isavuconazole in children with cancer.

Janine Nijhuis, Anouk M E Jansen, Tom F W Wolfs

|Jan 09, 2026
Intravenous lanadelumab for the treatment of moderately ill COVID-19 patients.

Job J Engel, Christine van Linge, W Joost Wiersinga

Pageof 10

Frequent Collaborators

12 joint publications

Paul E Verweij

8 joint publications

Catherijne A J Knibbe

7 joint publications

Jeroen Schouten

7 joint publications

Nynke G L Jager